001     287622
005     20250415112709.0
024 7 _ |a 10.1186/s40246-024-00576-x
|2 doi
024 7 _ |a pmid:38308339
|2 pmid
024 7 _ |a 1473-9542
|2 ISSN
024 7 _ |a 1479-7364
|2 ISSN
024 7 _ |a altmetric:159149467
|2 altmetric
037 _ _ |a DKFZ-2024-00276
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Ünal, Pelin
|0 P:(DE-He78)0149ac455a0174a847bd30162edf897b
|b 0
|e First author
|u dkfz
245 _ _ |a Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk.
260 _ _ |a London [u.a.]
|c 2024
|b Henry Stewart Publ.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1707140221_27093
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C055#LA:C055#
520 _ _ |a Genome-wide association studies (GWAS) are a powerful tool for detecting variants associated with complex traits and can help risk stratification and prevention strategies against pancreatic ductal adenocarcinoma (PDAC). However, the strict significance threshold commonly used makes it likely that many true risk loci are missed. Functional annotation of GWAS polymorphisms is a proven strategy to identify additional risk loci. We aimed to investigate single-nucleotide polymorphisms (SNP) in regulatory regions [transcription factor binding sites (TFBSs) and enhancers] that could change the expression profile of multiple genes they act upon and thereby modify PDAC risk. We analyzed a total of 12,636 PDAC cases and 43,443 controls from PanScan/PanC4 and the East Asian GWAS (discovery populations), and the PANDoRA consortium (replication population). We identified four associations that reached study-wide statistical significance in the overall meta-analysis: rs2472632(A) (enhancer variant, OR 1.10, 95%CI 1.06,1.13, p = 5.5 × 10-8), rs17358295(G) (enhancer variant, OR 1.16, 95%CI 1.10,1.22, p = 6.1 × 10-7), rs2232079(T) (TFBS variant, OR 0.88, 95%CI 0.83,0.93, p = 6.4 × 10-6) and rs10025845(A) (TFBS variant, OR 1.88, 95%CI 1.50,1.12, p = 1.32 × 10-5). The SNP with the most significant association, rs2472632, is located in an enhancer predicted to target the coiled-coil domain containing 34 oncogene. Our results provide new insights into genetic risk factors for PDAC by a focused analysis of polymorphisms in regulatory regions and demonstrating the usefulness of functional prioritization to identify loci associated with PDAC risk.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Association study
|2 Other
650 _ 7 |a Enhancer
|2 Other
650 _ 7 |a Pancreatic cancer
|2 Other
650 _ 7 |a Single nucleotide polymorphism
|2 Other
650 _ 7 |a Transcription factor binding site
|2 Other
700 1 _ |a Lu, Ye
|b 1
700 1 _ |a Bueno-de-Mesquita, Bas
|b 2
700 1 _ |a van Eijck, Casper H J
|b 3
700 1 _ |a Talar-Wojnarowska, Renata
|b 4
700 1 _ |a Szentesi, Andrea
|b 5
700 1 _ |a Gazouli, Maria
|b 6
700 1 _ |a Kreivenaite, Edita
|b 7
700 1 _ |a Tavano, Francesca
|b 8
700 1 _ |a Małecka-Wojciesko, Ewa
|b 9
700 1 _ |a Erőss, Bálint
|b 10
700 1 _ |a Oliverius, Martin
|b 11
700 1 _ |a Bunduc, Stefania
|b 12
700 1 _ |a Nóbrega Aoki, Mateus
|b 13
700 1 _ |a Vodickova, Ludmila
|b 14
700 1 _ |a Boggi, Ugo
|b 15
700 1 _ |a Giaccherini, Matteo
|b 16
700 1 _ |a Kondrackiene, Jurate
|b 17
700 1 _ |a Chammas, Roger
|b 18
700 1 _ |a Palmieri, Orazio
|b 19
700 1 _ |a Theodoropoulos, George E
|b 20
700 1 _ |a Bijlsma, Maarten F
|b 21
700 1 _ |a Basso, Daniela
|b 22
700 1 _ |a Mohelnikova-Duchonova, Beatrice
|b 23
700 1 _ |a Soucek, Pavel
|b 24
700 1 _ |a Izbicki, Jakob R
|b 25
700 1 _ |a Kiudelis, Vytautas
|b 26
700 1 _ |a Vanella, Giuseppe
|b 27
700 1 _ |a Arcidiacono, Paolo Giorgio
|b 28
700 1 _ |a Włodarczyk, Barbara
|b 29
700 1 _ |a Hackert, Thilo
|b 30
700 1 _ |a Schöttker, Ben
|0 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
|b 31
|u dkfz
700 1 _ |a Uzunoglu, Faik G
|b 32
700 1 _ |a Bambi, Franco
|b 33
700 1 _ |a Goetz, Mara
|b 34
700 1 _ |a Hlavac, Viktor
|b 35
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 36
|u dkfz
700 1 _ |a Perri, Francesco
|b 37
700 1 _ |a Carrara, Silvia
|b 38
700 1 _ |a Landi, Stefano
|b 39
700 1 _ |a Hegyi, Péter
|b 40
700 1 _ |a Dijk, Frederike
|b 41
700 1 _ |a Maiello, Evaristo
|b 42
700 1 _ |a Capretti, Giovanni
|b 43
700 1 _ |a Testoni, Sabrina Gloria Giulia
|b 44
700 1 _ |a Petrone, Maria Chiara
|b 45
700 1 _ |a Stocker, Hannah
|0 P:(DE-He78)104fae0755c89365b7ae32238b3f1f52
|b 46
|u dkfz
700 1 _ |a Ermini, Stefano
|b 47
700 1 _ |a Archibugi, Livia
|b 48
700 1 _ |a Gentiluomo, Manuel
|b 49
700 1 _ |a Cavestro, Giulia Martina
|b 50
700 1 _ |a Pezzilli, Raffaele
|b 51
700 1 _ |a Di Franco, Gregorio
|b 52
700 1 _ |a Milanetto, Anna Caterina
|b 53
700 1 _ |a Sperti, Cosimo
|b 54
700 1 _ |a Neoptolemos, John P
|b 55
700 1 _ |a Morelli, Luca
|b 56
700 1 _ |a Vokacova, Klara
|b 57
700 1 _ |a Pasquali, Claudio
|b 58
700 1 _ |a Lawlor, Rita T
|b 59
700 1 _ |a Bazzocchi, Francesca
|b 60
700 1 _ |a Kupcinskas, Juozas
|b 61
700 1 _ |a Capurso, Gabriele
|b 62
700 1 _ |a Campa, Daniele
|b 63
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 64
|e Last author
|u dkfz
773 _ _ |a 10.1186/s40246-024-00576-x
|g Vol. 18, no. 1, p. 12
|0 PERI:(DE-600)2147618-4
|n 1
|p 12
|t Human genomics
|v 18
|y 2024
|x 1473-9542
909 C O |o oai:inrepo02.dkfz.de:287622
|p VDB
|p OpenAPC
|p openCost
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)0149ac455a0174a847bd30162edf897b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 31
|6 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 36
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 46
|6 P:(DE-He78)104fae0755c89365b7ae32238b3f1f52
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 64
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HUM GENOMICS : 2022
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-04-12T15:07:29Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-04-12T15:07:29Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-04-12T15:07:29Z
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-25
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-10-25
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-10-25
915 p c |a APC keys set
|2 APC
|0 PC:(DE-HGF)0000
915 p c |a Local Funding
|2 APC
|0 PC:(DE-HGF)0001
915 p c |a DFG OA Publikationskosten
|2 APC
|0 PC:(DE-HGF)0002
915 p c |a DOAJ Journal
|2 APC
|0 PC:(DE-HGF)0003
920 2 _ |0 I:(DE-He78)C055-20160331
|k C055
|l Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 2
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 3
920 0 _ |0 I:(DE-He78)C055-20160331
|k C055
|l Genomische Epidemiologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED
980 _ _ |a APC


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21